Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
Sponsor: Beijing GoBroad Hospital
Summary
This is an investigator-initiated, open-label, single-arm, dose-escalation and dose-expansion study to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of MTM-H-001 in adult participants with B-cell-related autoimmune diseases.
Official title: An Open-Label, Single-Arm, Dose-Escalation and Expansion Basket Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Efficacy of MTM-H-001 in Patients With B-Cell-Related Autoimmune Diseases (ArchAid-002)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2026-06
Completion Date
2031-06
Last Updated
2026-05-18
Healthy Volunteers
No
Conditions
Interventions
MTM-H-001 Injection
Each participant receives MTM-H-001 Injection
Locations (1)
Beijing GoBroad Hospital
Beijing, Beijing Municipality, China